If you’re searching for sickle cell testing information — where to get tested and why it matters — here’s the short answer: a simple blood test called hemoglobin electrophoresis can identify both sickle cell disease and sickle cell trait, and it’s available at most hospitals, primary care clinics, community health centers, and specialized genetic testing labs. In the U.S., all 50 states include sickle cell screening in their mandatory newborn screening panels, but if you weren’t tested at birth or you’re planning to have children, you can request testing through your doctor at any age.
Now let’s talk about why this test is so critical. Sickle cell disease (SCD) affects approximately 100,000 Americans and millions worldwide. About 1 in 13 Black or African American babies is born with sickle cell trait, and roughly 1 in 365 will be born with sickle cell disease. Early detection — ideally at birth — reduces childhood mortality by over 90% because it allows doctors to start preventive antibiotics and vaccinations before life-threatening infections occur. Testing isn’t just for newborns, though. Adults who carry the trait often have no idea, and two carriers have a 25% chance of having a child with full-blown sickle cell disease with each pregnancy.
Who Should Get Sickle Cell Testing?
While newborn screening catches most cases today, there are several situations where older children and adults should actively seek testing:
- Family history of sickle cell disease or trait
- African, Mediterranean, Middle Eastern, Indian, or Hispanic ancestry — populations with higher carrier rates due to historical genetic protection against malaria
- Couples planning pregnancy who want to understand their carrier status
- Adults who were born outside the U.S. or in countries without routine newborn screening
- Anyone experiencing unexplained anemia, chronic pain episodes, or recurrent infections
A common misconception is that sickle cell disease only affects people of African descent. While prevalence is highest in that population, SCD occurs across multiple ethnic groups. The trait is found in people of Greek, Italian, Turkish, Saudi Arabian, and Indian heritage as well.
Types of Sickle Cell Tests and What They Measure
| Test | What It Detects | When It’s Used | Turnaround Time |
|---|---|---|---|
| Hemoglobin Electrophoresis | Separates hemoglobin types (HbA, HbS, HbC, HbF, etc.) | Newborn screening, initial diagnosis | 1–3 days |
| HPLC (High-Performance Liquid Chromatography) | Quantifies hemoglobin variants with high precision | Confirmatory testing, newborn screening | 1–3 days |
| Sickle Solubility Test (Sickledex) | Detects presence of HbS (yes/no) | Rapid screening in adults; cannot distinguish trait from disease | Minutes to hours |
| DNA / Genetic Analysis | Identifies exact beta-globin gene mutations | Confirmatory testing, prenatal diagnosis, genetic counseling | 1–4 weeks |
| Complete Blood Count (CBC) | Hemoglobin level, red blood cell indices | Supportive — shows anemia pattern but not diagnostic alone | Hours |
The gold standard for diagnosis is hemoglobin electrophoresis or HPLC, because these tests tell you exactly which hemoglobin variants are present and in what proportions. A person with sickle cell trait typically has about 55–60% HbA and 35–40% HbS. A person with sickle cell disease (HbSS) has 80–95% HbS with no normal HbA.
Where to Get a Sickle Cell Test
Getting tested is easier than most people think. Here are your main options:
- Your primary care doctor — can order hemoglobin electrophoresis with a standard blood draw
- Community health centers and free clinics — many offer sickle cell screening, especially in areas with higher-risk populations
- Hospitals and urgent care — can run sickle solubility tests on the spot if symptoms suggest SCD
- Genetic counseling centers — ideal for couples planning a pregnancy; they provide DNA-level testing and help interpret results
- Sickle cell disease organizations — groups like the Sickle Cell Disease Association of America (SCDAA) host free community screening events throughout the year
- At-home testing kits — some direct-to-consumer genetic tests now include sickle cell carrier status, though results should always be confirmed by a clinical lab
Insurance typically covers sickle cell testing when ordered by a physician, especially with a relevant family history or symptoms. Under the Affordable Care Act, newborn screening — including sickle cell — is covered as a preventive service with no out-of-pocket cost.
Sickle Cell Trait vs. Sickle Cell Disease: A Critical Distinction
Carrying one copy of the sickle gene gives you sickle cell trait (SCT). Carrying two copies — one from each parent — causes sickle cell disease. This distinction matters enormously.
People with sickle cell trait are generally healthy and asymptomatic. However, they’re not completely risk-free. Extreme physical exertion, dehydration, high altitude, and unpressurized aircraft cabins can, in rare cases, trigger complications like exertional rhabdomyolysis or splenic infarction. The NCAA now requires sickle cell trait testing for all Division I athletes.
Sickle cell disease, on the other hand, is a serious chronic illness. Patients experience vaso-occlusive crises (episodes of severe pain caused by sickled cells blocking blood vessels), chronic hemolytic anemia with hemoglobin levels often running 6–9 g/dL, increased stroke risk (particularly in children), organ damage over time, and a reduced life expectancy — though modern treatment has pushed median survival into the mid-to-late 50s, up from under 20 just decades ago.
What Happens After a Positive Test?
If testing reveals sickle cell disease, your doctor will typically refer you to a hematologist for ongoing management. Current standard-of-care treatments include:
- Hydroxyurea — the backbone of SCD treatment; increases fetal hemoglobin (HbF), reduces crises by 44%, and lowers mortality
- L-glutamine (Endari) — FDA-approved in 2017 to reduce acute complications
- Voxelotor (Oxbryta) — inhibits HbS polymerization, improving hemoglobin levels
- Crizanlizumab (Adakveo) — a monoclonal antibody that reduces vaso-occlusive crises
- Blood transfusions — used for stroke prevention, severe anemia, and acute chest syndrome
- Gene therapy — two gene therapies (Casgevy and Lyfgenia) were FDA-approved in December 2023, offering potential cures for eligible patients
If testing shows you carry the trait, no treatment is needed — but genetic counseling is strongly recommended before having children, especially if your partner’s status is unknown.
When to See a Doctor
Request sickle cell testing if you have a family history of the disease, belong to a higher-risk ethnic group, or are planning a pregnancy with a partner who may carry the trait. Seek urgent care if you or your child experience unexplained severe pain episodes, sudden vision changes, swelling of the hands and feet in infants (dactylitis), persistent fever above 101.3°F, or signs of stroke such as sudden weakness or slurred speech.
Frequently Asked Questions
Can I get a sickle cell test without a doctor’s order?
In some states, you can request direct-access lab testing through services like Quest Diagnostics or Labcorp without a physician’s order. Community screening events also don’t require a referral. However, clinical confirmation and genetic counseling should follow any positive result.
How much does sickle cell testing cost without insurance?
A hemoglobin electrophoresis test typically costs $30–$100 out of pocket at commercial labs. Genetic DNA testing is more expensive, ranging from $200–$500. Many community health programs offer free screening in high-prevalence areas.
If both parents have sickle cell trait, what are the odds for each pregnancy?
Each pregnancy carries a 25% chance the child will have sickle cell disease (HbSS), a 50% chance the child will have sickle cell trait (HbAS), and a 25% chance the child will have completely normal hemoglobin (HbAA). These odds are independent for every pregnancy — they don’t “average out” across children.
Can sickle cell disease be cured?
Yes — bone marrow (stem cell) transplant has been curative for decades, though it requires a matched donor and carries significant risks. The FDA approval of two gene therapies in late 2023 (Casgevy, which uses CRISPR technology, and Lyfgenia) has expanded curative options. These therapies use the patient’s own modified stem cells, eliminating the need for a donor match.
Does sickle cell trait protect against malaria?
Yes. Carrying one copy of the sickle gene provides roughly 60% protection against severe Plasmodium falciparum malaria. This survival advantage is why the sickle gene persisted at high frequencies in malaria-endemic regions — a classic example of balanced selection in human genetics.
